BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15982865)

  • 1. A twist in anti-inflammation: annexin 1 acts via the lipoxin A4 receptor.
    Gavins FN; Sawmynaden P; Chatterjee BE; Perretti M
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):211-9. PubMed ID: 15982865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N; Arita M; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice.
    Souza DG; Fagundes CT; Amaral FA; Cisalpino D; Sousa LP; Vieira AT; Pinho V; Nicoli JR; Vieira LQ; Fierro IM; Teixeira MM
    J Immunol; 2007 Dec; 179(12):8533-43. PubMed ID: 18056401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking insult from injury: lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells.
    Maderna P; Godson C
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):179-87. PubMed ID: 15978792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN
    Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct.
    Gavins FN; Kamal AM; D'Amico M; Oliani SM; Perretti M
    FASEB J; 2005 Jan; 19(1):100-2. PubMed ID: 15507472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoxins in gastric mucosal health and disease.
    Wallace JL; de Lima OM; Fiorucci S
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):251-5. PubMed ID: 16024242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation.
    El Kebir D; József L; Filep JG
    J Leukoc Biol; 2008 Sep; 84(3):600-6. PubMed ID: 18495783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation.
    Hashimoto A; Murakami Y; Kitasato H; Hayashi I; Endo H
    Biomed Pharmacother; 2007 Jan; 61(1):81-5. PubMed ID: 17184966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.
    Yacoubian S; Serhan CN
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
    Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
    J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN; Chiang N
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The annexin 1 receptor(s): is the plot unravelling?
    Perretti M
    Trends Pharmacol Sci; 2003 Nov; 24(11):574-9. PubMed ID: 14607080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and steroids: new mechanistic findings and avenues for drug discovery.
    Gilroy DW; Perretti M
    Curr Opin Pharmacol; 2005 Aug; 5(4):405-11. PubMed ID: 15955733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists.
    Dufton N; Perretti M
    Pharmacol Ther; 2010 Aug; 127(2):175-88. PubMed ID: 20546777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues.
    Norel X; Brink C
    Pharmacol Ther; 2004 Jul; 103(1):81-94. PubMed ID: 15251228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms.
    Gavins FN; Yona S; Kamal AM; Flower RJ; Perretti M
    Blood; 2003 May; 101(10):4140-7. PubMed ID: 12560218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes.
    Sawmynaden P; Perretti M
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1351-5. PubMed ID: 16973129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxin analogs: novel anti-inflammatory mediators.
    Gewirtz A
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1112-5. PubMed ID: 16312131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.